Related Experiment Video
Updated: Jun 1, 2026

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents
Published on: July 14, 2021
Impact of moderate coronary atherosclerosis on long-term left ventricular remodeling after aortic valve replacemen
Jose Antonio Linares Vicente1, Isaac Lacambra Blasco, Pilar Portero Perez
1Department of Cardiology, Lozano Blesa University Clinic Hospital, Zaragoza, Spain. joselinares1979@hotmail.com
Insights
Moderate coronary atherosclerosis impacts ventricular remodeling after aortic valve replacement. Patients without coronary issues showed better left ventricular (LV) mass and dimension reduction post-surgery.
Area of Science:
- Cardiology
- Cardiac Surgery
- Vascular Biology
Background:
- The impact of coronary atherosclerosis (CA+) on ventricular remodeling after aortic valve replacement (AVR) for aortic stenosis (AS) remains unclear.
- This study investigates the long-term effects of moderate, unaddressed coronary atherosclerosis on left ventricular (LV) remodeling post-AVR.
Purpose of the Study:
- To evaluate the influence of non-revascularized moderate coronary atherosclerosis on long-term left ventricular remodeling following aortic valve replacement for isolated aortic stenosis.
Main Methods:
- Coronary artery disease was assessed via coronariography in 66 patients undergoing AVR.
- Morphological and functional LV data were evaluated using echocardiography preoperatively and at long-term follow-up (3 ± 1.2 years).
Main Results:
- Patients without coronary atherosclerosis exhibited more significant hypertrophy regression and greater reverse remodeling of LV mass index (-55.8 ± 36 g/m² vs -28.4 ± 34 g/m², p=0.004).
- Greater reduction in LV dimensions (LVEDD: -4.1 ± 7.4 mm vs -2.2 ± 8.3 mm, p=0.04) and wall thickness (IVS: -3.3 ± 2.6 mm vs -1.6 ± 2.2 mm, p=0.01; PWT: -2.1 ± 2.1 mm vs 0.6 ± 2.1 mm, p=0.012) was observed in patients without CA+.
Conclusions:
- Unaddressed moderate coronary atherosclerosis is associated with reduced long-term left ventricular hypertrophy regression after AVR for AS.
- Coronary atherosclerosis negatively impacts the absolute reverse remodeling of LV mass index, LVEDD, IVS, and PWT post-AVR.
Background:
The role of coronary atherosclerosis (CA+) in ventricular remodeling after aortic valve replacement (AVR) for isolated aortic stenosis (AS) is not well defined. We sought to evaluate the impact of not revascularized moderate coronary atherosclerosis in long-term left ventricular (LV) remodeling after AVR.
Methods:
We assessed by coronariography the coronary artery disease in 66 patients referred for AVR and evaluated morphological and functional LV data by echocardiography both preoperatively and postoperatively (3 ± 1.2 years).
Results:
In patients without coronary atherosclerosis, hypertrophy regression was more intense and the absolute reverse remodeling was higher in LV mass index (-55.8 ± 36 g/m² vs -28.4 ± 34 g/m², p = 0.004), reduction of LV dimensions (LV end-diastolic diameter [LVEDD]: -4.1 ± 7.4 mm vs -2.2 ± 8.3 mm, p = 0.04), and regression of wall thickness (interventricular septum [IVS]: -3.3 ± 2.6 mm vs -1.6 ± 2.2 mm, p = 0.01; and posterior wall thickness [PWT]: -2.1 ± 2.1 mm vs 0.6 ± 2.1 mm, p = 0.012).
Conclusions:
After AVR for AS, not revascularized moderate coronary atherosclerosis determines a long-term lesser degree of LV hypertrophy regression and a worse absolute reverse remodeling of LV mass index, LVEDD, IVS and PWT.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Related Concept Videos
Aortic Regurgitation III: Medical Management
Aortic Regurgitation I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis I: Introduction
Mitral Regurgitation I: Introduction
Heart Failure II: Pathophysiology